AUGMENTIN, AUGMENTIN 600ES, AUGMENTIN XR (Amoxicillin-Clavulanate Potassium)

DOI: https://doi.org/10.1002/9781119220787.ch16
2017-08-30
Abstract:This chapter provides the basic characteristics, side effects/toxicity, drug interactions, and dosage information of the Augmentine, Augmentin 600ES, Augmentin (Amoxicillin‐Clavulanate Potassium). Augmentine binds penicillin‐binding protein, disrupting cell wall synthesis. The PBP can be altered, with reduced affinity. Decreased ability of the antibiotic to reach the PBP when bacteria decrease porin production, resulting in a decrease of the drug concentration within the cell. Augmentin indicated in the treatment of infections due to susceptible strains of microorganisms in the conditions: lower respiratory tract infections, otitis media, sinusitis, skin and skin structure infections, and urinary tract infections. Augmentin ES 600 Indicated for the treatment of pediatric patients with recurrent or persistent acute otitis media, with the following risk factors: antibiotic exposure for acute otitis media within the preceding 3 months, plus either age of 2 years or less or daycare attendance.
What problem does this paper attempt to address?